A Study to Determine Optimal Absorption of Single Dose Omega-3

Clinical trial NCT05491759 · COMPLETED

Trial details

NCT number: NCT05491759
Sponsor: RDC Clinical Pty Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Optimal Gastrointestinal Absorption of Omega-3

Start date: 2022-08-04
Primary completion: 2022-09-28
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.